InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- PharmAust secures largest ever single order of $1.02m. 21 Nov 2007 8:33AM $0.053 $0.230 risen by 333.96%
- Appendix 4C - quarterly 1 Nov 2007 8:50AM $0.061 $0.230 risen by 277.05%
- Reinstatement to Official Quotation 17 Oct 2007 7:05PM $0.040 $0.230 risen by 475%
- Suspension from Official Quotation 2 Oct 2007 4:15PM $0.038 $0.230 risen by 505.26%
- TGA Approves PharmAust Pain Relief Medicines 27 Sep 2007 3:56PM $0.040 $0.230 risen by 475%
- Commencement of Federal Court Proceedings 27 Sep 2007 9:07AM $0.055 $0.230 risen by 318.18%
- Supplementary Prospectus 21 Sep 2007 7:22PM $0.038 $0.230 risen by 505.26%
- Entitlements Issue Prospectus 12 Sep 2007 7:31PM $0.039 $0.230 risen by 489.74%
- Rights Issue 12 Sep 2007 7:31PM $0.039 $0.230 risen by 489.74%
- Preliminary Final Report 3 Sep 2007 8:30AM $0.050 $0.230 risen by 360%
- Working Capital and Re-Finance Facility 29 Aug 2007 9:41AM $0.042 $0.230 risen by 447.62%
- Appendix 4C - quarterly 31 Jul 2007 3:03PM $0.061 $0.230 risen by 277.05%
- PharmAust - CBI obtains Approval to work on Avian Flu Virus 28 Jun 2007 11:38AM $0.075 $0.230 risen by 206.67%
- Court Action with Advanced Healthgroup Group Ltd 21 Jun 2007 8:29AM $0.079 $0.230 risen by 191.14%
- PharmAust - CBI Completes Aquisition of Tripos 7 Jun 2007 10:56AM $0.089 $0.230 risen by 158.43%
- Awarded NZ$715000 for Specialist GMP Peptide Capabilities 31 May 2007 11:22AM $0.085 $0.230 risen by 170.59%
- Commitments Test Entity - Third Quarter Report 30 Apr 2007 12:57PM $0.080 $0.230 risen by 187.50%
- Placement and Rights Issue 20 Apr 2007 6:52PM $0.094 $0.230 risen by 144.68%
- Half Yearly Report/Half Year Accounts 26 Feb 2007 8:27AM $0.120 $0.230 risen by 91.67%
- PharmAust to Supply Five New Generic Drugs in Australia 20 Feb 2007 8:26AM $0.130 $0.230 risen by 76.92%
- TGA Approves PharmAust Generic Cholesterol Drug 15 Feb 2007 10:52AM $0.135 $0.230 risen by 70.37%
- Merger Proposal with Advance Healthcare Group 14 Feb 2007 9:07AM $0.135 $0.230 risen by 70.37%
- Completes Sale of Mimotopes 14 Feb 2007 9:07AM $0.135 $0.230 risen by 70.37%
- Reinstatement to Official Quotation 14 Feb 2007 9:07AM $0.125 $0.230 risen by 84%
- Suspension from Official Quotation 9 Feb 2007 9:53AM n/a $0.230 n/a

726 - 750 of 796 results

Page 30 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.